Table 3.

HPV prevalence according to sample type in the tested population of 33,137 samples from women and 10,997 samples from men (12 samples from men with missing sample type are excluded)

Sample typen samplesHPV-positive samples% HPV positivity (95% CI)
UrineWomen10,8402,91926.9 (26.1–27.7)
Men9,7871,00910.3 (9.7–10.9)
Combined urine and genital swab sampleaWomen13,5746,04744.5 (43.7–45.3)
Men571221.1 (10.5–31.7)
VaginaWomen531630.2 (17.8–42.6)
MenN/AN/AN/A
CervixWomen7,3333,05841.7 (40.6–42.8)
MenN/AN/AN/A
Combined cervical and urethral sampleWomen68131346.0 (42.3–49.7)
MenN/AN/AN/A
UrethraWomen451022.2 (10.1–34.3)
Men59713021.8 (18.5–25.1)
RectumWomen10330.0 (1.6–58.4)
Men1736537.6 (30.4–44.8)
EyeWomen10832.8 (0–5.9)
Men9733.1 (0–6.5)
PharynxWomen8222.4 (0–5.7)
Men270145.2 (2.6–7.8)
OtherWomen41116339.7 (35.0–44.4)
Men1616.3 (0–18.2)
  • aGenital swab: for women, includes cervical, vaginal, or unspecified genital swabs; for men, unspecified genital swabs. N/A, not applicable.